Published in Vaccine Weekly, July 6th, 2005
Study 1: Alpha-lipoic acid plays a protective role in the oxidative vulnerability triggered by A-beta amyloid vaccination.
"Recent reports indicate that beta-amyloid peptide (A-beta) vaccine based therapy for Alzheimer disease (AD) may be on the horizon. There are however, concerns about the safety of this approach. Immunization with A-beta has several disadvantages, because it crosses the blood brain barrier and cause inflammation and neurotoxicity. The present work is aimed to study the protective effective of alpha-lipoic acid (LA) in the oxidative...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly